thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - agentes antineoplásicos - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
reserpina
sgpharma pvt. ltd; - reserpina - tableta - 0,25 mg
reserpina 0,25 mg capsulas
laboratorios klinos, c.a. - reserpina - capsula - 0,25 mg
nieser enro 10
nieser - antibioticos quimioterapicos y otros - aves;
nieser lite
nieser - vitaminas minerales anabolicos y otros - aves; bovinos; equinos; ovinos; porcinos;
dutasterida apotex ag 0,5 mg capsulas blandas efg
apotex europe b.v. - dutasterida - excipientes: butilhidroxitolueno,glicerol - fÁrmacos usados en la hipertrofia prostÁtica benigna - inhibidores de la testosterona 5-alfa reductasa - dutasterida
reserpina comprimidos 0,25 mg
laboratorios andrÓmaco s.a. - sin formulas
reserpina comprimidos 0,25 mg
laboratorio chile s.a. - sin formulas
reserpina comprimidos 0,25 mg
mintlab co. s.a. - sin formulas
reserpina comprimidos de 0,25 mg
recben xenerics farmacÉutica ltda. - sin formulas